Recent Quotes (30 days)

You have no recent quotes
chg | %

Angel Biotechnology Holdings Plc news

   Watch this stock
Showing stories 1 - 10 of about 71   

Articles published

ABH 0.0500
price chart
Angel Biotechnology calls in administrators
The company has a subsidiary, Angel Biomedical, which is also in administration. Share-trading in AIM-listed Angel Biotechnology Holdings has ceased. KPMG said the companies had incurred losses, most recently as a result of difficult trading conditions.
Related articles »  
Scancell's immunotherapy platform to fight brain cancer
Scancell Holdings PLC (LON:SCLP) technology is being used to develop a vaccine for the treatment of one of the most common and most aggressive forms of brain cancer.
New contract build global footprint, says Venn Life Sciences Holdings plc CEO
The contract is with a European biotech group to carry out a phase II trial. ... Meet Anglo Asian Mining Plc, Landore Resources Ltd.
Intelligent Energy Holding PLC shares jump on the back of job losses
Shares in Intelligent Energy Holding PLC (LON:IEH) surged more than 60% today after it announced a proposed restructuring of its troubled energy technology business that included 200 job losses.
Fox Marble Holdings PLC gets its foot in the door at London luxury apartments
Most of us are familiar with “gazumping” in Britain's heated property market, but marble quarrying firm Fox Marble PLC (LON:FOX) has done a bit of gazumping of its own, displacing an incumbent supplier of stone for the luxury apartments in London's ...
Cyan Holdings PLC soars on Iran meter contract
Smart metering firm Cyan Holdings PLC (LON:CYAN) sparked up to be London's top share riser as it revealed it had won a �10mln order to supply its products in Iran.
Cyan Holdings PLC
Cyan Holdings plc is listed on the AIM market in London and is based in Cambridge UK. The company has three wholly owned subsidiaries, Cyan Technology Ltd (a company registered in England and Wales), Cyan Technology India Private Limited (a ...
Broker praise for Savannah Resources management and shareholder support
The production difficulties at the Lace mine have delayed the start of sustainable cashflow, triggered the need for significant additional finance as well as the deferral of capital repayments on the project loans and the need to strengthen the ...
Epistem changes its name to Genedrive
“While the name of our PLC changes from Epistem Holdings to Genedrive, we will operate two brands under that banner," Budd told Proactive.
C4X Discovery Holdings PLC bags a billion molecules (virtually)
Drug discovery and development company C4X Discovery Holdings plc has bought a suite of advanced drug discovery technologies from the administrator that should prove highly complementary to the company's existing know-how.